Publications by authors named "Daniel Bellissimo"

Claim this Profile
D
Detection rates of multigene panel and exome testing in patients with previous negative BRCA1/2 results.
Jewel L Wasson, Trinity N Sprague, Darcy L Thull, Maureen May, Kathleen E Vitale, Daniel Bellissimo

Fam Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Early use of whole exome sequencing unveils HNRNPU-related neurodevelopmental disorder and answers additional clinical questions through reanalysis.
Erika Nicole Dreikorn, Christine Munro, Natasha Robin Berman, Amina Kunovac, Daniel Bellissimo

Front Genet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy-number variants in the ACMG secondary finding genes: A reporting framework for clinical cytogeneticists.
Mahmoud Aarabi, Helia Darabi, Aryan Bashar, Daniel Bellissimo, Aleksandar Rajkovic

Genet Med Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges and opportunities of offering and integrating training in clinical molecular genetics and clinical cytogenetics: A survey of LGG Fellowship Program Directors.
Joshua L Deignan, Vimla Aggarwal, Allen E Bale, Daniel B Bellissimo, Jessica K Booker

Genet Med Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of copy-number variants in a large cohort of patients with von Willebrand disease reveals a relationship between disrupted regions and disease type.
Brooke Sadler, Pamela A Christopherson, Crystal L Perry, Daniel B Bellissimo, Sandra L Haberichter

Res Pract Thromb Haemost· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Margaret V Ragni, Scott D Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Daniel Bellissimo

Lancet Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
Pamela A Christopherson, Sandra L Haberichter, Veronica H Flood, Crystal L Perry, Brooke E Sadler, Daniel B Bellissimo

J Thromb Haemost· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number alterations involving 59 ACMG-recommended secondary findings genes.
Svetlana A Yatsenko, Mahmoud Aarabi, Jie Hu, Urvashi Surti, Damara Ortiz, Daniel Bellissimo

Clin Genet· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH.
Karyn Megy, Kate Downes, Ilenia Simeoni, Loredana Bury, Joannella Morales, Daniel B Bellissimo

J Thromb Haemost· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autism spectrum disorder in females with ARHGEF9 alterations and a random pattern of X chromosome inactivation.
Mahmoud Aarabi, Elena Kessler, Suneeta Madan-Khetarpal, Urvashi Surti, Daniel Bellissimo

Eur J Med Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD.
Veronica H Flood, Jill M Johnsen, Caroline Kochelek, Tricia L Slobodianuk, Pamela A Christopherson, Daniel B Bellissimo

Res Pract Thromb Haemost· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of complete phenotyping in prenatal whole exome sequencing.
Mahmoud Aarabi, Olivia Sniezek, Huaiyang Jiang, Devereux N Saller, Daniel Bellissimo

Hum Genet· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal GRB10 microdeletion is a novel cause of cystic placenta: Spectrum of genomic changes in the etiology of enlarged cystic placenta.
Urvashi Surti, Svetlana Yatsenko, Jie Hu, Daniel Bellissimo, W Tony Parks

Placenta· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.
Ilenia Simeoni, Jonathan C Stephens, Fengyuan Hu, Sri V V Deevi, Karyn Megy, Daniel B Bellissimo

Blood· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Veronica H Flood, Pamela A Christopherson, Joan Cox Gill, Kenneth D Friedman, Sandra L Haberichter, Daniel B Bellissimo

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crucial role for the VWF A1 domain in binding to type IV collagen.
Veronica H Flood, Abraham C Schlauderaff, Sandra L Haberichter, Tricia L Slobodianuk, Paula M Jacobi, Daniel B Bellissimo

Blood· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
Daniel B Bellissimo, Pamela A Christopherson, Veronica H Flood, Joan Cox Gill, Kenneth D Friedman

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Von Willebrand disease in the United States: a perspective from Wisconsin.
Veronica H Flood, Joan Cox Gill, Kenneth D Friedman, Daniel B Bellissimo, Sandra L Haberichter

Semin Thromb Hemost· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
Kevin J Pirelli, Bradley C Pietz, Susan T Johnson, Holly L Pinder, Daniel B Bellissimo

Prenat Diagn· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A third allele of the HPA-5 (Br) platelet alloantigen system identified in investigating a case of neonatal thrombocytopenia.
Julie A Peterson, Maria L Gitter, Bradley Pietz, Daniel Bellissimo, Brian Curtis

Transfusion· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform.
Kathleen Hopp, Kathleen Weber, Daniel Bellissimo, Susan T Johnson, Bradley Pietz

Transfusion· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors.
Alan E Mast, Tisha M Foster, Holly L Pinder, Craig A Beczkiewicz, Daniel B Bellissimo

Transfusion· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.
C Sue Richards, Sherri Bale, Daniel B Bellissimo, Soma Das, Wayne W Grody

Genet Med· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice guidelines and proficiency testing for molecular assays.
Daniel B Bellissimo,

Transfusion· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.
Sandra L Haberichter, Michael Balistreri, Pamela Christopherson, Patricia Morateck, Stefana Gavazova, Daniel B Bellissimo

Blood· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis